drugset / Trial / NCT05130814

EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers

NCT05130814

Completed 48 enrolled Emoled
RandomizedParallel-groupOpen-labelTreatment

Summary

The present clinical study aims to verify the effectiveness and safety of the blue light photobiomodulation therapy with EmoLED medical device in supporting the reparative process of the area of the second and third stage decubitus lesion, comparing this method with the effectiveness of the therapy commonly used in the clinical field.

Timeline

Start
2021-12-01
Primary completion
2024-03-07
Completion
2024-03-07

Drugs

EvaluationDrugModalityDoseRoute
Background Sodium Hyaluronate Other / unclassified
Background metallic silver Unknown
Background zinc cream Unknown

Indications